Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrin Beyer

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Acta Neuropathologica|July 18, 2006
Alpha-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancersKatrin Beyer
Biomarkers in Medicine|November 26, 2013
The first genetic biomarker for dementia with Lewy bodiesKatrin Beyer
International Journal of Molecular Sciences|July 8, 2020
Epigenetics in Lewy Body Diseases: Impact on Gene Expression, Utility as a Biomarker, and Possibilities for TherapyAintzane Urbizu, Katrin Beyer
Soft Computing|November 1, 2021
Pareto-like sequential sampling heuristic for global optimisationMahmoud Shaqfa, Katrin Beyer
Journal of Neuropathology and Experimental Neurology|November 7, 2007
Protein aggregation mechanisms in synucleinopathies: commonalities and differencesKatrin Beyer, Aurelio Ariza
Current Medicinal Chemistry|November 11, 2008
The therapeutical potential of alpha-synuclein antiaggregatory agents for dementia with Lewy bodiesKatrin Beyer, Aurelio Ariza
Molecular Neurobiology|August 28, 2012
α-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegenerationKatrin Beyer, Aurelio Ariza
Genes|January 26, 2018
Alternative Splicing of Alpha- and Beta-Synuclein Genes Plays Differential Roles in SynucleinopathiesAna Gámez-Valero, Katrin Beyer
Neurobiology of Disease|September 19, 2021
Alternative platelet activation pathways and their role in neurodegenerative diseasesPaula Ferrer-Raventós, Katrin Beyer
International Journal of Molecular Sciences|February 11, 2023
Obtaining miRNA from Saliva-Comparison of Sampling and Purification MethodsAintzane Urbizu, Laura Arnaldo, Katrin Beyer
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Acta Neuropathologica|July 18, 2006
Alpha-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancersKatrin Beyer
Biomarkers in Medicine|November 26, 2013
The first genetic biomarker for dementia with Lewy bodiesKatrin Beyer
International Journal of Molecular Sciences|July 8, 2020
Epigenetics in Lewy Body Diseases: Impact on Gene Expression, Utility as a Biomarker, and Possibilities for TherapyAintzane Urbizu, Katrin Beyer
Soft Computing|November 1, 2021
Pareto-like sequential sampling heuristic for global optimisationMahmoud Shaqfa, Katrin Beyer
Journal of Neuropathology and Experimental Neurology|November 7, 2007
Protein aggregation mechanisms in synucleinopathies: commonalities and differencesKatrin Beyer, Aurelio Ariza
Current Medicinal Chemistry|November 11, 2008
The therapeutical potential of alpha-synuclein antiaggregatory agents for dementia with Lewy bodiesKatrin Beyer, Aurelio Ariza
Molecular Neurobiology|August 28, 2012
α-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegenerationKatrin Beyer, Aurelio Ariza
Genes|January 26, 2018
Alternative Splicing of Alpha- and Beta-Synuclein Genes Plays Differential Roles in SynucleinopathiesAna Gámez-Valero, Katrin Beyer
Neurobiology of Disease|September 19, 2021
Alternative platelet activation pathways and their role in neurodegenerative diseasesPaula Ferrer-Raventós, Katrin Beyer
International Journal of Molecular Sciences|February 11, 2023
Obtaining miRNA from Saliva-Comparison of Sampling and Purification MethodsAintzane Urbizu, Laura Arnaldo, Katrin Beyer
Pageof 6